Purity: | 99% |
---|---|
Model Number: | 319460-85-0 |
Brand Name: | NJBN STEROID |
Grade Standard: | Medicine Grade |
Type: | Cancer Therapy |
Place of Origin: | China (Mainland) |
EINECS No.: | 319460-85-0 |
MF: | C22H18N4OS |
Other Names: | Benzamide |
CAS No.: | 319460-85-0 |
Sample: | Free |
Market: | Worldwide |
Quick Details
Specifications
_____________________________________________________________________________________________________________
Axitinib
Synonyms: AXITINIB; Benzamide, N-methyl-2-[[3-[(1E)-2-(2-pyridinyl)ethenyl]-1H-indazol-6-yl]thio]-; N-METHYL-2-{[3-((E)-2-PYRIDIN-2-YLVINYL)-1H-INDAZOL-6-YL]SULFANYL}BENZAMIDE; N-Methyl-2-((3-((1E)-2-(pyridin-2-yl)ethenyl)-1H-indazol-6-yl)sulfanyl)benzamide; AVERMECTINB; Axitinib for research; AG013736; N-Methyl-2-[[3-[(1E)- 2-(2-pyridinyl)ethenyl] -1H-indazol-6-yl]thio]benzamide
CAS: 319460-85-0
MF: C22H18N4OS
MW: 386.47
Purity: 99%
Appearance: White to off-White Powder
Categories:
All Inhibitors; Inhibitors; Intermediates & Fine Chemicals; Pharmaceuticals; Protein Kinase Inhibitors and Activators; Pfizer compounds; API; AG 013736
_____________________________________________________________________________________________________________
COA
Items of analysis |
Specification |
Results |
Description |
off-white powder |
Conforms |
Loss on drying |
NMT 1.0% |
0.7% |
Water content |
NMT 0.5% |
0.13% |
Single impurity |
NMT0.1% |
0.07% |
Total impurity |
NMT 0.5% |
0.29% |
Purity(HPLC) |
NLT 99.0% |
99.71% |
Conclusion |
Qualified |
_____________________________________________________________________________________________________________
Description of Axitinib
Axitinib is a small molecule tyrosine kinase inhibitor developed . It has been shown to significantly inhibit growth of breast cancer in animal (xenograft) models and has shown partial responses in clinical trials with renal cell carcinoma (RCC) and several other tumour types. It has been shown to significantly Inhibit growth of breast cancer in xenograft models and has been successful in trials with renal cell carcinoma (RCC) and several other tumor types.
_____________________________________________________________________________________________________________
Hot selling pharmaceutical raw materials
Clarithromycin CAS: 81103-11-9
PF-2341066/Crizotinib CAS: 877399-52-5
Rapamycin CAS: 53123-88-9
Trilostane CAS: 13647-35-3
Tacrolimus CAS: 104987-11-3
Ketoconazole CAS: 65277-42-1
Levamisole hydrochloride CAS: 16595-80-5
Daunorubicin hydrochloride CAS: 23541-50-6
Folic acid CAS: 59-30-3
Itraconazole CAS: 84625-61-6
Everolimus CAS: 159351-69-6
Zoledronic acid CAS: 118072-93-8
Aminoglutethimide (Cytadren) CAS: 125-84-8
Rasagiline mesylate CAS: 161735-79-1
Clopidogrel hydrogen sulfate CAS: 135046-48-9
Doxepin hydrochloride CAS: 1229-29-4
Naphazoline hydrochloride CAS: 550-99-2
TELMISARTAN CAS: 144701-48-4
Pramipexole CAS: 104632-26-0
Furazabol CAS: 1239-29-8
Triamcinolone acetonide CAS: 76-25-5
Etilefrine hydrochloride CAS: 943-17-9
Promethazine hydrochloride CAS: 58-33-3
O-PHOSPHORYLETHANOLAMINE CAS: 1071-23-4
Cilastatin CAS : 82009-34-5
Lovastatin CAS: 75330-75-5
Erythromycin CAS: 114-07-8
Pregabalin / Lyrica CAS: 148553-50-8
DEXTROMETHORPHAN HYDROBROMIDE CAS: 125-69-9
Macitentan CAS: 441798-33-0
Etoricoxib CAS: 202409-33-4
PARECOXIB SODIUM CAS: 198470-85-8
Tirofiban hydrochloride monohydrate CAS: 150915-40-5
Apixaban CAS: 503612-47-3
Palbociclib CAS: 571190-30-2
Anacetrapib CAS: 875446-37-0
Dexamethasone CAS: 50-02-2
Dutasteride CAS: 164656-23-9
Finasteride CAS: 98319-26-7